To evaluate the potential clinical association of ICAM-1 and uPAR in breast cancer patients, we first compared ICAM-1 and uPAR protein expression between different breast cancer subtypes using Clinical Proteomic Tumor Analysis Consortium (CPTAC) data sets. This evidence concerns the gene PLAUR and breast cancer.